AT1 Atomo Diagnostics Limited
Healthcare · Medical Devices
· website
$0.02
52wk 0.02 – 0.05
Overall
—
Value
—
Growth
—
Health
—
Quality
—
Momentum
—
Dividend
—
Price
About Atomo Diagnostics Limited
Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. The company offers blood test devices, such as Pascal, Curie, Galileo, Elion, and Florey under the AtomoRapid brand. It also offers HIV Rapid self-Test device; and digital health solutions. Atomo Diagnostics Limited was incorporated in 2010 and is headquartered in Leichhardt, Australia.
Fundamental trends
Financial statements
Loading…
Key metrics
Market cap
$16.24M
P/E (trailing)
—
P/E (forward)
-0.02
EPS (trailing)
-0.01
Dividend yield
—
Payout ratio
0.0%
Beta
1.10
EV / EBITDA
-2.50
Price / Book
2.25
ROE
-56.6%
Operating margin
-111.7%
Net margin
-101.4%
Total cash
$3.51M
Total debt
$500,513
Current ratio
2.78
Debt / Equity
0.08
Free cash flow
$-1.40M
Avg volume
1.12M
Latest annual results
(FY ending 30 Jun 2025)
- Revenue$3.25M
- Gross profit$1.38M
- Operating income-$7.01M
- Net income-$4.97M
- Diluted EPS-0.01
- Free cash flow-$1.99M
- Net debt-$3.03M